| C-reactive protein and clinical outcomes in patients with COVID-19 NR Smilowitz, D Kunichoff, M Garshick, B Shah, M Pillinger, JS Hochman, ... European heart journal 42 (23), 2270-2279, 2021 | 399 | 2021 |
| Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week MS Garshick, NL Ward, JG Krueger, JS Berger Journal of the American College of Cardiology 77 (13), 1670-1680, 2021 | 97 | 2021 |
| Apolipoprotein AI) promotes atherosclerosis regression in diabetic mice by suppressing myelopoiesis and plaque inflammation TJ Barrett, E Distel, AJ Murphy, J Hu, MS Garshick, Y Ogando, J Liu, ... Circulation 140 (14), 1170-1184, 2019 | 92 | 2019 |
| Inflammasome signaling and impaired vascular health in psoriasis MS Garshick, TJ Barrett, T Wechter, S Azarchi, JU Scher, A Neimann, ... Arteriosclerosis, thrombosis, and vascular biology 39 (4), 787-798, 2019 | 77 | 2019 |
| Neutrophil subsets, platelets, and vascular disease in psoriasis HL Teague, NJ Varghese, LC Tsoi, AK Dey, MS Garshick, JI Silverman, ... JACC: Basic to Translational Science 4 (1), 1-14, 2019 | 69 | 2019 |
| Activated platelets induce endothelial cell inflammatory response in psoriasis via COX-1 MS Garshick, M Tawil, TJ Barrett, CM Salud-Gnilo, M Eppler, A Lee, ... Arteriosclerosis, thrombosis, and vascular biology 40 (5), 1340-1351, 2020 | 58 | 2020 |
| CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health YA Elnabawi, MS Garshick, M Tawil, TJ Barrett, EA Fisher, KL Sicco, ... Journal of the American Academy of Dermatology 84 (4), 913-920, 2021 | 37 | 2021 |
| Cardiovascular risk factor control and lifestyle factors in young to middle-aged adults with newly diagnosed obstructive coronary artery disease MS Garshick, GD Vaidean, A Vani, JA Underberg, JD Newman, JS Berger, ... Cardiology 142 (2), 83-90, 2019 | 35 | 2019 |
| Psoriasis and cardiovascular disease: novel mechanisms and evolving therapeutics B Weber, JF Merola, ME Husni, M Di Carli, JS Berger, MS Garshick Current atherosclerosis reports 23, 1-11, 2021 | 32 | 2021 |
| The use of primary prevention statin therapy in those predisposed to atherosclerosis M Garshick, JA Underberg Current atherosclerosis reports 19, 1-8, 2017 | 31 | 2017 |
| Characterization of PCSK9 in the blood and skin of psoriasis MS Garshick, Y Baumer, AK Dey, R Grattan, Q Ng, HL Teague, ZX Yu, ... Journal of Investigative Dermatology 141 (2), 308-315, 2021 | 30 | 2021 |
| COVID-19 and the heart and vasculature: novel approaches to reduce virus-induced inflammation in patients with cardiovascular disease BS Kadosh, MS Garshick, J Gaztanaga, KJ Moore, JD Newman, ... Arteriosclerosis, thrombosis, and vascular biology 40 (9), 2045-2053, 2020 | 28 | 2020 |
| Location of acute coronary artery thromboses in patients with and without chronic kidney disease DM Charytan, RE Kuntz, M Garshick, S Candia, MF Khan, L Mauri Kidney international 75 (1), 80-87, 2009 | 21 | 2009 |
| Cardiovascular and venous thromboembolic risk with Janus kinase inhibitors in immune‐mediated inflammatory diseases: a systematic review and meta‐analysis of randomized trials MH Maqsood, BN Weber, RH Haberman, KI Lo Sicco, S Bangalore, ... ACR Open Rheumatology 4 (10), 912-922, 2022 | 17 | 2022 |
| Reduction in dietary trans fat intake is associated with decreased LDL particle number in a primary prevention population M Garshick, H Mochari-Greenberger, L Mosca Nutrition, Metabolism and Cardiovascular Diseases 24 (1), 100-106, 2014 | 17 | 2014 |
| A randomized open-label clinical trial of lipid-lowering therapy in psoriasis to reduce vascular endothelial inflammation MS Garshick, K Drenkova, TJ Barrett, F Schlamp, EA Fisher, S Katz, ... The Journal of investigative dermatology 142 (6), 1749, 2022 | 16 | 2022 |
| Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice MS Garshick, C Nikain, M Tawil, S Pena, TJ Barrett, BG Wu, Z Gao, ... Scientific reports 11 (1), 8966, 2021 | 14 | 2021 |
| A case of cardiogenic shock secondary to complement-mediated myopericarditis from influenza B infection M Siskin, S Rao, A Rapkiewicz, S Bangalore, M Garshick Canadian Journal of Cardiology 33 (10), 1335. e1-1335. e3, 2017 | 14 | 2017 |
| Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris M Koschitzky, K Navrazhina, MS Garshick, J Gonzalez, J Han, S Garcet, ... Experimental dermatology 31 (9), 1341-1351, 2022 | 11 | 2022 |
| Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases: A Systematic Review and Meta-Analysis JP Ingrassia, MH Maqsood, JM Gelfand, BN Weber, S Bangalore, ... JAMA dermatology, 2023 | 10 | 2023 |
Edward A FisherProfessor of Medicine, NYU在 nyumc.org 的电子邮件经过验证
